Here are the stocks that are in news today:
Results Today: Orchid Pharma, Huhtamaki PPL, Firstsource Solutions
January Trade Deficit at USD 15.17 billion, Imports at USD 41.14 billion & Exports at USD 25.97 billion
Granules India: USFDA completes inspection at company’s Hyderabad unit with 2 observations
Cipla gets USFDA nod for Deferasirox - CNBC-TV18
Alkem Labs gets USFDA nod for Hypertension Drug Chlorthalidon - CNBC-TV18
Dr Reddy's Laboratories - USFDA determines Duvvada’s formulations manufacturing unit as voluntary action initiated (VAI)
RITES emerges as successful bidder for supply of locomotives, coaches worth Rs 680 crore
Hero MotoCorp launches BS-VI Splendor+, price starting Rs 59,600
Dr Reddy's: US FDA completes audit of Srikakulum plant, with zero observation
Zydus Cadila launches a fast tracked programme to develop vaccine for the novel coronavirus, 2019-nCoV (COVID-19)
PNC Infratech - Credit Analysis & Research Limited (CARE) assigned CARE AA; Stable rating to subsidiary, PNC Raebareli Highways, long term bank facilities of Rs 490.89 crore
Punjab & Sind Bank revised the Marginal Cost of Fund Based Lending Rate (MCLR) for different tenors effective from 16.02.2020
Indiabulls Housing Finance - CARE Ratings has revised the long-term rating to “CARE AA” with Stable outlook
Lupin launches bacterial conjunctivitis drug Moxifloxacin Ophthalmic solution
SAIL Q3: Consolidated net loss at Rs 343.6 crore versus profit at Rs 638.8 crore, revenue up 4.4 percent at Rs 16,542.5 crore versus Rs 15,842.2 crore, YoY
Glenmark Pharma Q3: Consolidated net profit up 64.1 percent at Rs 190.8 crore versus Rs 116.3 crore, revenue up 7.1 percent at Rs 2,735.5 crore versus Rs 2,555 crore, YoY
ONGC Q3: Net profit down 33.7 percent at Rs 4,151.6 crore versus Rs 6,263.1 crore, revenue down 3.2 percent at Rs 23,710 crore versus Rs 24,492.6 crore, QoQ
Sun TV Q3: Net profit up 6.3 percent at Rs 373.5 crore versus Rs 351 crore, revenue down 9.9 percent at Rs 815 crore versus Rs 904 crore, YoY
SREI Infra Q3: Consolidated net Profit down 34.4 percent at Rs 60.03 crore versus Rs 91.56 crore, revenue down 10.03 percent at Rs 1,450.5 crore versus Rs 1,617.5 crore
IRB Infra Q3: Net profit down 27 percent at Rs 159.7 crore versus Rs 218.9 crore, revenue down 2.6 percent at Rs 1,742.6 crore versus Rs 1,788.5 crore, YoY